Budenoside-formoterol reliever therapy versus maintenance budenoside plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicenter, superiority, randomized controlled trial - Hardy, J (Lancet, 2019)
et al.